Insmed (INSM) Short-term Investments (2010 - 2026)

Insmed's Short-term Investments history runs 9 years deep, the most recent figure standing at $641.3 million for Q1 2026.

• On a quarterly basis, Short-term Investments fell 19.45% year-over-year to $641.3 million in Q1 2026; TTM through Mar 2026 was $641.3 million, a 19.45% decrease from a year earlier, with the FY2025 full-year figure at $919.6 million, up 4.64% from the prior year.
• Short-term Investments eased to $641.3 million in Q1 2026 per INSM's latest filing, from $919.6 million in the prior quarter.
• Across five years, Short-term Investments topped out at $1.3 billion in Q3 2025 and bottomed at $29.8 million in Q1 2023.
• The 5-year median for Short-term Investments is $304.9 million (2023), against an average of $501.5 million.
• Biggest YoY gain for Short-term Investments was 301.48% in 2023; the steepest drop was 75.07% in 2023.
• Year by year, Short-term Investments stood at $74.2 million in 2022, then jumped by 301.48% to $298.1 million in 2023, then soared by 194.83% to $878.8 million in 2024, then increased by 4.64% to $919.6 million in 2025, then slumped by 30.26% to $641.3 million in 2026.
• Per Business Quant, the three latest INSM Short-term Investments figures stand at $641.3 million (Q1 2026), $919.6 million (Q4 2025), and $1.3 billion (Q3 2025).